SCHEMBL1326727

SCHEMBL1326727

CCOC(=O)CC1CCC(C(c2ccccc2)N(C)C)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.41
PTGIR P43119 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
SLC6A2 P23975 4/20 0.39
SLC6A3 Q01959 4/20 0.39
SLC6A4 P31645 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
KDM4E B2RXH2 1/20 0.39
CHRNB2 P17787 1/20 0.39
CHRNB4 P30926 1/20 0.39
CHRNA3 P32297 1/20 0.39
CHRNA4 P43681 1/20 0.39
POLB P06746 1/20 0.38
CHRM2 P08172 1/20 0.38
HTR1A P08908 1/20 0.38
ADRA2A P08913 1/20 0.38
CHRM1 P11229 1/20 0.38
DRD1 P21728 1/20 0.38
ADRA1A P35348 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1326498 0.88 L3MBTL1 (0.37) L3MBTL1POLBLMNACYP1A2
SCHEMBL1326903 0.88 KLK7 (0.44) PTGIRL3MBTL1TDP1SMN1; SMN2KDM4E
SCHEMBL1326717 0.86 OPRL1 (0.41) PTGIROPRM1LMNACYP2D6
SCHEMBL1328757 0.82 HSD11B1 (0.39) PTGIRCHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL27731163 0.78 TACR2 (0.42) PTGIRSLC6A2SLC6A3CHRNB2CHRNB4
SCHEMBL1326845 0.77 MAPT (0.44) L3MBTL1SLC6A2SLC6A3SLC6A4TDP1
SCHEMBL1326844 0.77 MAPT (0.44) L3MBTL1SLC6A2SLC6A3SLC6A4TDP1
SCHEMBL1326984 0.77 KDM4E (0.40) PTGIRSLC6A3SLC6A4TDP1KDM4E
SCHEMBL1326523 0.76 KLK7 (0.44) TP53L3MBTL1TDP1SMN1; SMN2POLB
SCHEMBL493563 0.76 OPRM1 (0.35) PTGIRCHRNB2CHRNB4CHRNA3CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8058475-B2 Substituted cyclohexylmethyl compounds GRUENENTHAL GMBH (DE) 2011-11-15 US claimed
EP-1989174-B1 SUBSTITUTED CYCLOHEXYLMETHYL DERIVATIVES GRUENENTHAL GMBH (DE) 2011-08-03 EP claimed
US-20090286833-A1 Substituted Cyclohexylmethyl Compounds GRUENENTHAL GMBH (DE) 2009-11-19 US claimed
US-8058475-B2 Substituted cyclohexylmethyl compounds GRUENENTHAL GMBH (DE) 2011-11-15 US disclosed
US-20090286833-A1 Substituted Cyclohexylmethyl Compounds GRUENENTHAL GMBH (DE) 2009-11-19 US disclosed
US-7589113-B2 Substituted oxadiazole compounds and their use as opioid receptor ligands GRUENENTHAL GMBH (DE) 2009-09-15 US disclosed
US-20090005427-A1 SUBSTITUTED OXADIAZOLE COMPOUNDS AND THEIR USE AS OPIOID RECEPTOR LIGANDS GRUENENTHAL GMBH (DE) 2009-01-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090005427-A1 SUBSTITUTED OXADIAZOLE COMPOUNDS AND THEIR USE AS OPIOID RECEPTOR LIGANDS OPRM1, OPRD1, OPRK1 TP53 4881/4885PTGIR 740/4885L3MBTL1 2114/4885
US-20090286833-A1 Substituted Cyclohexylmethyl Compounds CNR1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, C1R TP53 2729/4885PTGIR 516/4885L3MBTL1 4461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.